The Office of the U.S. Trade Representative (USTR) has announced that it will again extend Section 301 product exclusions for imports from China of medical care products needed to address the COVID-19 pandemic. The USTR will extend product exclusions on 81 medical care products, as set forth in Annex B of USTR’s announcement, for an additional six months.  These product exclusions were set to expire on May 31, 2022, but will now be extended through November 30, 2022.  The exclusion extensions are available for any product that meets the description in the product exclusion.  Further, the scope of each exclusion and modification is governed by the scope of the 10-digit Harmonized Tariff Schedule of the United States (HTSUS) statistical reporting numbers and product descriptions in the relevant section of Chapter 99 of the HTSUS.

See past Update of November 12, 2021, for additional details on past extensions.